Soligenix
SNGX
#10972
Rank
ยฃ5.98 M
Marketcap
ยฃ0.27
Share price
4.90%
Change (1 day)
-78.16%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -ยฃ8.7 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ8.96 Million a decrease over its 2024 earnings that were of -ยฃ7.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ8.7 Million-2.91%
2025 -ยฃ8.96 Million26.72%
2024 -ยฃ7.07 Million22.96%
2023 -ยฃ5.75 Million-45.74%
2022 -ยฃ10.59 Million11.88%
2021 -ยฃ9.47 Million-32.37%
2020 -ยฃ14 Million83.18%
2019 -ยฃ7.64 Million11.57%
2018 -ยฃ6.85 Million19.29%
2017 -ยฃ5.74 Million33%
2016 -ยฃ4.32 Million-19.7%
2015 -ยฃ5.38 Million5.16%
2014 -ยฃ5.11 Million
2010 -ยฃ5.77 Million26.12%
2009 -ยฃ4.58 Million75.1%
2008 -ยฃ2.62 Million-45.38%
2007 -ยฃ4.79 Million-22.84%
2006 -ยฃ6.2 Million66.15%
2005 -ยฃ3.73 Million-16.65%
2004 -ยฃ4.48 Million13.28%
2003 -ยฃ3.95 Million-11.88%
2002 -ยฃ4.49 Million-59.44%
2001 -ยฃ11.06 Million378.18%
2000 -ยฃ2.32 Million-38.53%
1999 -ยฃ3.76 Million-18.43%
1998 -ยฃ4.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.80 B-224,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ5.21 B-59,115.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ5.41 B-61,279.19%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ13.72 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ31.56 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.21 B-13,813.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-ยฃ2.08 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-ยฃ71.87 Million 712.56%๐Ÿ‡บ๐Ÿ‡ธ USA